Shirouchi, Yuko
24  results:
Search for persons X
?
1

Recent advances and future perspectives of T-cell engagers ..:

Shirouchi, Yuko ; Maruyama, Dai
Japanese Journal of Clinical Oncology.  54 (2024)  4 - p. 376-385 , 2024
 
?
2

Complex karyotype determined using conventional cytogenetic..:

Uryu, Hideki ; Mishima, Yuko ; Ishihara, Yuko...
Journal of Clinical and Experimental Hematopathology.  64 (2024)  1 - p. 10-20 , 2024
 
?
7

P-312 Impact of the IF system using HYDRASHIFTon response e..:

Shirouchi, Yuko ; Kaihara, Kazumi ; Sekita, Tsunaki...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S210 , 2023
 
?
11

P-128: Accompanying with additional complex karyotype is a ..:

Uryu, Hideki ; Nishimura, Noriko ; Mishima, Yuko...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S105 , 2021
 
?
12

The clonal evolution during long-term clinical course of mu..:

Mishima, Yuko ; Mishima, Yuji ; Shirouchi, Yuko...
International Journal of Hematology.  113 (2020)  2 - p. 279-284 , 2020
 
?
13

Insignificance of surveillance imaging in patients with dif..:

Fukuta, Takanori ; Nishimura, Noriko ; Shirouchi, Yuko...
International Journal of Hematology.  111 (2020)  4 - p. 567-573 , 2020
 
?
14

Long-term Follow-up of Clonal Evolutions of Myeloma Cells i..:

Shirouchi, Yuko ; Mishima, Yuko ; Mishima, Yuji...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e78 , 2019
 
?
15

Angiotensin II receptor blockers might reduce a cardiotoxic..:

Fukuta, Takanori ; Nishimura, Noriko ; Shirouchi, Yuko...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e255 , 2019
 
1-15